Dapeng Wei
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Glycosylation and Glycoproteins Research 5
- Immunology 14
- Toxin Mechanisms and Immunotoxins 6
- Immune Cell Function and Interaction 4
- Co-authors
- Shengjun Mao (5 shared papers)Liangke Zhang (4 shared papers)Shixiang Hou (4 shared papers)Xiangrong Song (3 shared papers)Yi Lü (1 shared paper)Junqin Li (3 shared papers)Hua Li (2 shared papers)Lihua Dong (2 shared papers)
- Journals
- Journal of Pharmacy and Pharmacology (1 paper)International Journal of Pharmaceutics (1 paper)International Journal of Biological Sciences (1 paper)Advances in Therapy (1 paper)Nanotechnology (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Dapeng Wei
49 papers receiving 550 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 152
- Biomaterials 121
- Pharmaceutical Science 46
- Molecular Biology 301
- Pharmacology 30
Countries citing papers authored by Dapeng Wei
This map shows the geographic impact of Dapeng Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dapeng Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dapeng Wei more than expected).
Fields of papers citing papers by Dapeng Wei
This network shows the impact of papers produced by Dapeng Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dapeng Wei. The network helps show where Dapeng Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Dapeng Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 105 | |
| 2 | 2014 | 88 | |
| 3 | 2021 | 40 | |
| 4 | Preparation, characterization and uptake by primary cultured rat hepatocytes of liposomes surface-modified with glycyrrhetinic acid. | 2007 | 33 |
| 5 | 2021 | 32 | |
| 6 | 2002 | 31 | |
| 7 | 2021 | 24 | |
| 8 | 2009 | 20 | |
| 9 | 2021 | 18 | |
| 10 | Effect of anaphylatoxin C3a, C5a on the tubular epithelial-myofibroblast transdifferentiation in vitro. | 2011 | 17 |
| 11 | 2017 | 16 | |
| 12 | 2017 | 15 | |
| 13 | 2011 | 11 | |
| 14 | 2018 | 10 | |
| 15 | 2014 | 8 | |
| 16 | 2023 | 6 | |
| 17 | 2016 | 6 | |
| 18 | 2019 | 6 | |
| 19 | 2023 | 5 | |
| 20 | 2009 | 5 |
About Dapeng Wei
Dapeng Wei is a scholar working on Molecular Biology, Immunology, Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 51 papers that have together received 556 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (6 papers), Cancer, Lipids, and Metabolism (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cancer-related molecular mechanisms research (5 papers), Glycosylation and Glycoproteins Research (5 papers), Cell Adhesion Molecules Research (4 papers), Hepatitis B Virus Studies (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Cancer Research (152 citations), Biomaterials (121 citations), Pharmaceutical Science (46 citations), Molecular Biology (301 citations) and Pharmacology (30 citations). Dapeng Wei has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Shengjun Mao, Liangke Zhang, Shixiang Hou, Xiangrong Song, Yi Lü, Junqin Li, Hua Li, Lihua Dong, Shuo Zhang and Xiaodong Wang. Their work appears in journals such as Journal of Pharmacy and Pharmacology, International Journal of Pharmaceutics, International Journal of Biological Sciences, Advances in Therapy and Nanotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.